Drug Shortage Report for DEXAMETHASONE-OMEGA

Last updated on 2019-06-28 History
Report ID 63420
Drug Identification Number 02204266
Brand name DEXAMETHASONE-OMEGA
Common or Proper name Dexamethasone Sodium Phosphate Injection USP
Company Name OMEGA LABORATORIES LIMITED
Market Status MARKETED
Active Ingredient(s) DEXAMETHASONE PHOSPHATE
Strength(s) 4MG
Dosage form(s) LIQUID
Route of administration INTRA-ARTICULAR INTRALESIONAL INTRAMUSCULAR INTRAVENOUS SOFT TISSUE INJECTION
Packaging size 10 x 1 mL vial
ATC code H02AB
ATC description CORTICOSTEROIDS FOR SYSTEMIC USE, PLAIN
Reason for shortage Disruption of the manufacture of the drug.
Anticipated start date
Actual start date 2019-05-15
Estimated end date Unknown
Actual end date 2019-06-17
Shortage status Resolved
Updated date 2019-06-28
Company comments On allocation.
Health Canada comments
Tier 3 Status No
Contact Address 11177 HAMON
MONTREAL, QUEBEC
CANADA H3M 3E4
Company contact information info@omegalaboratory.com - 1-800-363-0584

Version History

Click on "Compare" below to view the full report history and compare to other versions.

Version Number Date Updated Language
v19 2019-06-28 French Compare
v18 2019-06-28 English Compare
v17 2019-05-27 French Compare
v16 2019-05-27 English Compare
v15 2019-01-13 French Compare
v14 2019-01-13 English Compare
v13 2019-01-12 English Compare
v12 2018-12-21 French Compare
v11 2018-12-21 English Compare
v10 2018-10-16 French Compare
v9 2018-10-16 English Compare
v8 2018-10-05 French Compare
v7 2018-10-05 English Compare
v6 2018-10-05 French Compare
v5 2018-10-05 English Compare
v4 2018-10-05 French Compare
v3 2018-10-05 English Compare
v2 2018-10-05 French Compare
v1 2018-10-05 English Compare

Showing 1 to 19 of 19